SCHEMBL5355667

SCHEMBL5355667

CCCCCCCCCCCC(=O)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](C=O)OC

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
MAPK1 P28482 1/20 0.49
LMNA P02545 4/20 0.44
PRKCA P17252 5/20 0.44
PRKCE Q02156 2/20 0.44
PRKCQ Q04759 2/20 0.44
PRKCD Q05655 2/20 0.44
KDM4E B2RXH2 1/20 0.43
DUSP3 P51452 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 2/20 0.40
DGKA P23743 1/20 0.40
FAAH O00519 1/20 0.39
HPGD P15428 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899724 1.00 MAPT (0.49) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL2563584 1.00 MAPT (0.49) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL789885 0.94 PRKCA (0.51) MAPTMAPK1PRKCAPRKCEPRKCQ
SCHEMBL8179685 0.92 MAPT (0.51) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL11506064 0.92 MAPT (0.51) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL8201074 0.92 MAPT (0.51) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL2129639 0.90 MAPT (0.49) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL1534016 0.89 MAPT (0.48) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL9225414 0.85 MAPT (0.53) MAPTMAPK1LMNAPRKCAPRKCE
SCHEMBL9227207 0.85 MAPT (0.53) MAPTMAPK1LMNAPRKCAPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115884744-A Composition for caring skin 莱雅公司 2023-03-31 CN disclosed
CN-110022845-B Foamable compositions 莱雅公司 2022-10-04 CN disclosed
CN-111107908-B Compositions comprising ellagic acid compounds 莱雅公司 2022-10-04 CN disclosed
CN-109890351-B Composition for natural skin lightening effect 莱雅公司 2022-04-08 CN disclosed
CN-107771073-B Composition comprising an associative thickener 莱雅公司 2021-08-31 CN disclosed
CN-113164358-A Straightening method for keratin fibers 莱雅公司 2021-07-23 CN disclosed
CN-113164361-A Personal care compositions 高露洁-棕榄公司 2021-07-23 CN disclosed
CN-112469385-A Foaming composition 莱雅公司 2021-03-09 CN disclosed
CN-112399844-A Composition with long-lasting masking effect 莱雅公司 2021-02-23 CN disclosed
CN-111479485-A Hair dyeing kit and composition for use in hair dyeing kit 莱雅公司 2020-07-31 CN disclosed
US-20140142202-A1 STRUCTURED AQUEOUS SURFACTANT SYSTEMS CONOPCO, INC., D/B/A UNILEVER 2014-05-22 US disclosed
EP-2697350-A1 STRUCTURED AQUEOUS SURFACTANT SYSTEMS Unilever PLC (GB) 2014-02-19 EP disclosed
EP-2696838-A2 OIL-IN-WATER EMULSIONS Unilever PLC (GB) 2014-02-19 EP disclosed
US-20140031437-A1 OIL-IN-WATER EMULSIONS CONOPCO, INC. D/B/A UNILEVER 2014-01-30 US disclosed
EP-1464322-B1 Use of compositions containing a chosen fluorescent dye and a chosen amphoteric or nonionic surfactant for dyeing human kerateous fibres with a bleaching effect OREAL (FR) 2013-06-05 EP disclosed
WO-2012139818-A1 STRUCTURED AQUEOUS SURFACTANT SYSTEMS UNILEVER PLC (GB) 2012-10-18 WO disclosed
WO-2012139817-A2 OIL-IN-WATER EMULSIONS UNILEVER PLC (GB) 2012-10-18 WO disclosed
US-7198650-B2 Method of dyeing human keratin materials with a lightening effect with compositions comprising at least one fluorescent dye and at least one amphoteric or nonionic surfactant, composition thereof, process thereof, and device therefor L'OREAL S.A. (FR) 2007-04-03 US disclosed
US-20050005371-A1 Method of dyeing human keratin materials with a lightening effect with compositions comprising at least one fluorescent dye and at least one amphoteric or nonionic surfactant, composition thereof, process thereof, and device therefor L'OREAL S.A. (FR) 2005-01-13 US disclosed
EP-1464322-A1 Use of compositions containing a chosen fluorescent dye and a chosen amphoteric or nonionic surfactant for dyeing human kerateous fibres with a bleaching effect L'OREAL (FR) 2004-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050005371-A1 Method of dyeing human keratin materials with a lightening effect with compositions comprising at least one fluorescent dye and at least one amphoteric or nonionic surfactant, composition thereof, process thereof, and device therefor KRT18, S100A11, S100A4 MAPT 2448/4885MAPK1 1848/4885LMNA 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.